Table 2.
Dependent Variables | |||
---|---|---|---|
Abbreviations | Full Names | Diagnosis | Diagnostic Criteria |
HE_sbp | Systolic blood pressure (Mean value of 2–3 BP measurements) | ≥80 mmHg | Hypertension |
HE_dbp | Diastolic blood pressure (Mean value of 2–3 BP measurements) | ≥140 mmHg | |
HE_BMI | Body mass index | ≥23 kg/m2 | Overweight/obesity |
HE_glu | Fasting blood glucose | ≥126 mg/dL (7.0 mmol/L) |
T2DM |
HE_HbA1c | Glycated hemoglobin | ≥6.5% | |
HE_chol | Total cholesterol | ≥240 mg/dL | Dyslipidemia |
HE_HDL_st2 | Calibration of high-density lipoprotein cholesterol | <40 mg/dL | |
HE_TG | Triglyceride | ≥200 mg/dL |
HE_BMI, overweight/obesity; HE_chol, total cholesterol; HE_dbp, diastolic blood pressure (mean value of 2–3 blood pressure measurements); HE_glu, fasting blood glucose; E_HbA1c, glycated hemoglobin; HE_HDL_st2, calibration of high-density lipoprotein cholesterol; HE_sbp, systolic blood pressure (mean value of 2–3 blood pressure measurements); HE_TG, triglyceride; T2DM, type 2 diabetes mellites. Dyslipidemia, according to the Korean Society of Lipid and Atherosclerosis, dyslipidemia is defined as any one of the following: total cholesterol level ≥ 40 mg/dL, high-density lipoprotein cholesterol level < 40 mg/dL, triglyceride level ≥ 200 mg/dL, low-density lipoprotein cholesterol level ≥ 160 mg/dL, or the use of a lipid-lowering drug; hypertension, according to Korean hypertension, hypertension was defined when systolic blood pressure was ≥140 mmHg or diastolic blood pressure was ≥80 mmHg; overweight/obesity, according to the Korean Society for the study of obesity; overweight/obesity defined when body mass index was 23 kg/m2 or higher; T2DM, according to the Korean Diabetes Association (KDA) T2DM was defined as fasting plasma glucose levels ≥ 126 mg/dL (7.0 mmol/L) or glycated hemoglobin ≥ 6.5%.